These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1319182)

  • 1. Inactivation of viruses related to hepatitis C virus by pasteurization in human plasma derivatives.
    Nowak T; Klockman U; Hilfenhaus J
    Biologicals; 1992 Mar; 20(1):83-5. PubMed ID: 1319182
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
    Hilfenhaus J; Gröner A; Nowak T; Weimer T
    Transfusion; 1997 Sep; 37(9):935-40. PubMed ID: 9308641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of HIV, HBV, HCV related viruses and other viruses in human plasma derivatives by pasteurisation.
    Nowak T; Niedrig M; Bernhardt D; Hilfenhaus J
    Dev Biol Stand; 1993; 81():169-76. PubMed ID: 8174799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives.
    Hilfenhaus J; Niedrig M; Nowak T
    Dev Biol Stand; 1993; 81():117-23. PubMed ID: 8174794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus safety of human immunoglobulins: efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure.
    Nowak T; Gregersen JP; Klockmann U; Cummins LB; Hilfenhaus J
    J Med Virol; 1992 Mar; 36(3):209-16. PubMed ID: 1314286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus inactivation of fresh plasma.
    Mohr H
    Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin glue safety: inactivation of potential viral contaminants by pasteurization of the human plasma components.
    Hilfenhaus J; Weidmann E
    Arzneimittelforschung; 1985; 35(11):1617-9. PubMed ID: 3004516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virus safety of fresh frozen plasma].
    Sugg U
    Beitr Infusionsther; 1989; 24():56-9. PubMed ID: 2481549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inactivation of viruses which can potentially contaminate blood products.
    Horowitz B
    Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A; Walker E
    Lancet; 1995 Aug; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC; Mosley JW
    Lancet; 1995 Aug; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus and intravenous immune globulin.
    Macy E
    JAMA; 1997 Feb; 277(8):627; author reply 627-8. PubMed ID: 9039874
    [No Abstract]   [Full Text] [Related]  

  • 13. Assays for viral sequences and their value in validation of viral elimination.
    Saldanha J
    Dev Biol Stand; 1993; 81():231-6. PubMed ID: 8174807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromatographic removal of viruses from plasma derivatives.
    Burnouf T
    Dev Biol Stand; 1993; 81():199-209. PubMed ID: 8174804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infections from contaminated 99mTc-sestamibi.
    Hung JC
    J Nucl Med; 2007 May; 48(5):847-8. PubMed ID: 17475974
    [No Abstract]   [Full Text] [Related]  

  • 16. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
    Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
    Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing of blood for antibodies to hepatitis C virus--implications for plasma pools used in the preparation of blood products.
    Minor P
    Biologicals; 1991 Jul; 19(3):253-6. PubMed ID: 1659432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Inactivation of viruses in Factor XIII concentrate by pasteurization].
    Mauler R; Hilfenhaus J
    Arzneimittelforschung; 1984; 34(11):1524-7. PubMed ID: 6543127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus safety of pooled fresh-frozen plasma inactivated by solvent/detergent treatment.
    Prince AM; Horowitz B
    Beitr Infusionsther; 1993; 31():21-4. PubMed ID: 7693256
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatitis C virus in the hemodialysis setting: detecting viral RNA from blood port caps by reverse transcription-polymerase chain reaction.
    Hardy NM; Chiao J; Arora N; Mars R; Jenkins SG
    Clin Nephrol; 2000 Aug; 54(2):143-6. PubMed ID: 10968691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.